Hepatitis C Virus Genotype 4 and Response to Combination Therapy with Interferon-α2b plus Ribavirin

  1. Savino Bruno, MD;
  2. Andrea Crosignani, MD; and
  3. Giovanni Battista Pinzello, MD
  1. S. Paolo University of Milan Italy; Milan 20142, Italy (Bruno, Crosignani) Liver Unit Crespi Niguarda Hospital Milan; Milan 20100, Italy (Pinzello)

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified …

    « Previous | Next Article »Table of Contents